As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

It's a daycare procedure and doesn't require hospitalisation. However, it is an expensive treatment. Will my health insurance ...

Treating diabetic retinopathy (DR) is still a significant challenge for clinicians and remains a leading cause of blindness worldwide. NovaGo Therapeutics is developing a human antibody therapy ...

Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

Patients with diabetic retinopathy need special care while pregnant, according to a speaker at Retina 2025. Irena Tsui, MD, said hormonal, metabolic and vascular changes during pregnancy can lead to ...

Diabetic retinopathy involves the changes for the blood vessels in your eye due to the high sugars that are in your body from diabetes, if you're a diabetic and you notice changes to your vision ...

With the advent of the 21st century, healthcare practitioners have witnessed a dramatic increase in the number of people being diagnosed with diabetes globally. According to the International ...

The historic pace of recruitment in both studies underscores the enthusiasm in the retina community for AXPAXLI. In 2025, we will also target diabetic retinopathy. Our HELIOS study has demonstrated ...